![]() Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. | ||
Founding Date | Founding Date 2015 | Founding Date 2017 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Gaithersburg, US HQ | Locations Wilmington, US HQ Rehovot, IL Wilmington, US |
Employees | Employees 78 | Employees 29 |
Valuation ($) | Valuation ($) 4.7 b | Valuation ($) 7.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $22.3m (FY, 2025) | Revenue (est.) $692k (FY, 2022) |
Net income | Net income ($228.9m) (FY, 2025) | Net income ($38m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 200m | Total funding raised $ 47m |

Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.
View company